Baxter signs over kidney care arm to investment firm in $3.5bn deal

By Yahoo! Finance | Aug 13, 2024 at 09:23 AM EST

Baxter has agreed to sell its kidney care segment to Carlyle for $3.5bn, following plans to improve performance and pay off debts. The spin-out, named Vantive, will focus on dialysis and organ support therapies, with hopes of long-term success and innovation.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.